This inventor holds 36 USPTO granted patents and 5 published patent applications, plus 9 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Romark Laboratories L.c., S.p.r.l. Phavic, Belmac Corporation. Active years: 1976-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (1976)
- S. Clearwater, FL (US) (1993)
- Clearwater, FL (US) (1995 - 2000)
- Tampa, FL (US) (2015)
- St. Petersburg, FL (US) (2012 - 2023)
Company Filing History:
30 out of 38 
2 out of 2 
1 out of 1 Years Active: 1976-2023
Areas of Expertise:
Title: **Innovative Contributions of Jean-Francois Rossignol in the Field of Pharmaceutical Patents**
Introduction
Jean-Francois Rossignol, based in St. Petersburg, FL, has made significant strides in the pharmaceutical industry, holding an impressive total of 33 patents. His inventions primarily focus on medical compounds and methods that address viral infections, particularly influenza and hepatitis C. Rossignol’s work is crucial in the realm of developing effective treatments that enhance public health.
Latest Patents
Among his latest innovations, Rossignol has developed a series of groundbreaking patents. One notable patent is centered around "Compounds and methods for treating influenza." This invention details methods for treating and preventing influenza infections by inhibiting the maturation processes of the influenza virus's hemagglutinin (HA) using specific compounds. It also includes formulations that combine these compounds with other agents to enhance effectiveness.
Another significant patent addresses "Controlled release pharmaceutical formulations of nitazoxanide." This patent provides solid dosage formulations that feature both controlled release and immediate release portions of nitazoxanide or its analogues. Specifically, it encompasses a bilayer solid oral dosage form, where the first layer is composed of a controlled release formulation and the second layer contains an immediate release formulation. This innovation also presents methods for using these formulations in treating hepatitis C, showcasing Rossignol’s versatility and ingenuity in pharmaceutical development.
Career Highlights
Throughout his career, Jean-Francois Rossignol has played a pivotal role in the research and development sectors of prominent pharmaceutical companies. One of his notable associations has been with Romark Laboratories, where he contributed to advancements in medicinal chemistry and therapeutic formulations.
Collaborations
Rossignol has collaborated with esteemed professionals in the field, including J Edward Semple and Marc S Ayers. These collaborations have facilitated innovative approaches to drug development, further strengthening the impact of his work on treating viral infections.
Conclusion
Jean-Francois Rossignol’s contributions to pharmaceutical innovations through his extensive patent portfolio illustrate his commitment to advancing medical science. His impactful inventions not only provide new methods for treating critical viral infections but also lay the groundwork for future research and development in the pharmaceutical industry. With 33 patents to his name, Rossignol continues to be a significant figure in the quest for effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile